Regulation of Expression and Pathogenic Potential of Human Foamy Virus In Vitro and in Transgenic Mice

  • A. Aguzzi
  • S. Marino
  • R. Tschopp
  • A. Rethwilm
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 206)


Increasing scientific interest in the foamy virus subgroup of retroviruses during the last few years has been due to two discoveries; (1) the molecular biology of foamy viruses shows some close similarities to that of lentiviruses and of the HTLV/BLV group of retroviruses, in addition to some features which set the foamy viruses apart from all other retroviruses. Moreover (2), transgenic mouse systems demonstrated for the first time a pathogenic potential of foamy viruses, i.e., induction of a fatal encephalopathy and myopathy in mice expressing various combinations of foamy virus genes.


Human Immunodeficiency Virus Transgenic Mouse Human Immunodeficiency Virus Type Acquire Immune Deficiency Syndrome Foamy Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Achong BG, Epstein MA (1978) Preliminary seroepidemiological studies on the human syncytial virus. J Gen Virol 40: 175–181PubMedGoogle Scholar
  2. Achong BG, Mansell PW, Epstein MA, Clifford P (1971) An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst 46: 299–307PubMedGoogle Scholar
  3. Aguzzi A (1993) The foamy virus family: molecular biology, epidemiology and neuropathology. Biochim Biophys Acta 1155: 1–24PubMedGoogle Scholar
  4. Aguzzi A, Theuring F (1994) An improved in situ beta-galactosidase staining for histological analysis of transgenic mice. Histochemistry 102: 477–481PubMedGoogle Scholar
  5. Aguzzi A, Wagner EF, Williams RL, Courtneidge SA (1990) Sympathetic hyperplasia and neuro-blastomas in transgenic mice expressing polyoma middle T antigen. New Biol 2: 533–543PubMedGoogle Scholar
  6. Aguzzi A, Kleihues P, Heckl K, Wiestier OD (1991) Cell-type specific tumor induction by oncogenes in fetal forebrains transplants. Oncogene 6: 113–118PubMedGoogle Scholar
  7. Aguzzi A, Bothe K, Anhauser I, Horak I, Rethwilm A, Wagner EF (1992a) Expression of human foamy virus is differentially regulated during development in transgenic mice. New Biol 4: 225–237PubMedGoogle Scholar
  8. Aguzzi A, Ellmeier W, Weith A (1992b) Dominant and recessive molecular changes in neuroblastoma. Brain Pathol 2: 195–208PubMedGoogle Scholar
  9. Aguzzi A, Brandner S, Sure U, Rüedi D, Isenmann S (1994) Transgenic and knock-out mice: models of neurological disease. Brain Pathol 4: 3–20PubMedGoogle Scholar
  10. Amborski GF, Storz J, Keney D, Lo J, McChesney AE (1987) Isolation of a retrovirus from the American bison and its relation to bovine retroviruses. J Wildl Dis 23: 7–11PubMedGoogle Scholar
  11. Bartholoma A, Muranyi W, Flügel RM (1992) Bacterial expression of the capsid antigen domain and identification of native gag proteins in spumavirus-infected cells. Virus Res 23: 27–38PubMedGoogle Scholar
  12. Baunach G, Maurer B, Hahn H, Kranz M, Rethwilm A (1993) Functional analysis of human foamy virus accessory reading frames. J Virol 67: 5411–5418PubMedGoogle Scholar
  13. Blair WS, Bogerd H, Cullen BR (1994) Genetic analysis indicates that the human foamy virus Bel-1 protein contains a transcription activation domain of the acidic class. J Virol 68: 3803–3808PubMedGoogle Scholar
  14. Bosch ML, Earl PL, Fargnoli K, Picciafuoco S, Giombini F, Wong Staal F, Franchini G (1989) Identification of the fusion peptide of primate immunodeficiency viruses. Science 244: 694–697PubMedGoogle Scholar
  15. Bothe K, Aguzzi A, Lassmann H, Rethwilm A, Horak I (1991) Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes. Science 253: 555–557PubMedGoogle Scholar
  16. Brenner TJ, Dahl KE, Olson B, Miller G, Andiman WA (1991) Relation between HIV-1 syncytium inhibition antibodies and clinical outcome in children. Lancet 337: 1001–1005PubMedGoogle Scholar
  17. Brown P, Nemo G, Gajdusek DC (1978) Human foamy virus: further characterization, seroepi-demiology, and relationship to chimpanzee foamy viruses. J Infect Dis 137: 421–427PubMedGoogle Scholar
  18. Brown P, Moreau-Dubois MC, Gajdusek DC (1982) Persistent asymptomatic infection of the laboratory mouse by simian foamy virus type 6: a new model of retrovirus latency. Arch Virol 71: 229–234PubMedGoogle Scholar
  19. Budka H (1986) Multinucleated giant cells in brain: a hallmark of the acquired immune deficiency syndrome (AIDS). Acta Neuropathol (Berl) 69: 253–258Google Scholar
  20. Camerini D, Seed B (1990) A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site. Cell 60: 747–754PubMedGoogle Scholar
  21. Cameron KR, Birchall SM, Moses MA (1978) Isolation of foamy virus from patient with dialysis encephalopathy. Lancet 2: 79666Google Scholar
  22. Campbell M, Renshaw Gegg L, Renne R, Luciw PA (1994) Characterization of the internal promoter of simian foamy viruses. J Virol 68: 4811–4820PubMedGoogle Scholar
  23. Cavard C, Zider A, Vernet M, Bennoun M, Saragosti S, Grimber G, Briand P (1990) In vivo activation by ultraviolet rays of the human immunodeficiency virus type 1 long terminal repeat. J Clin Invest 86: 1369–1374PubMedGoogle Scholar
  24. Cullen BR (1991) Human immunodeficiency virus as a prototypic complex retrovirus. J Virol 65: 1053–1056PubMedGoogle Scholar
  25. Davis MG, Kenney SC, Kamine J, Pagano JS, Huang ES (1987) Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc Natl Acad Sci USA 84: 8642–8646PubMedGoogle Scholar
  26. Doolittle RF, Feng DF, McClure MA, Johnson MS (1990) Retrovirus phylogeny and evolution. Curr Top Microbiol Immunol 157: 1–18PubMedGoogle Scholar
  27. Elliott JF, Pohajdak B, Talbot DJ, Shaw J, Paetkau V (1988) Phorbol diester-inducible, cyclosporine-suppressible transcription from a novel promoter within the mouse mammary tumor virus env gene. J Virol 62: 1373–1380PubMedGoogle Scholar
  28. Erlwein O, Rethwilm A (1993) Bel-1 transactivator responsive sequences in the long terminal repeat of human foamy virus. Virology 196: 256–268PubMedGoogle Scholar
  29. European Collaborative Study (1991) Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet 337: 253–260Google Scholar
  30. Flügel RM, Rethwilm A, Maurer B, Darai G (1987) Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveals two novel genes. EMBO J 6: 2077–2084PubMedGoogle Scholar
  31. Freed EO, Myers DJ, Risser R (1990) Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoproteinai] gp41. Proc Natl Acad Sci USA 87: 4650–4654PubMedGoogle Scholar
  32. Gallaher WR (1987) Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell 50: 327–328PubMedGoogle Scholar
  33. Garrett ED, He F, Bogerd HP, Cullen BR (1993) Transcriptional trans activators of human and simian foamy viruses contain a small, highly conserved activation domain. J Virol 67: 6824–6827PubMedGoogle Scholar
  34. Gendelman HE, Phelps W, Feigenbaum L, Ostrove JM, Adachi A, Howley PM, Khoury G, Ginsberg HS, Martin MA (1986) Trans-activation of the huan immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc Natl Acad Sci USA 83: 9759–9763PubMedGoogle Scholar
  35. Giangaspero F, Scanabissi E, Baldacci MC, Betts CM (1989) Massive neuronal destruetiona in human immunodeficiency virus (HIV) encephalitis. A clinico-pathological study of a pédiatrie case. Acta Neuropathol (Berl) 78: 662–665PubMedGoogle Scholar
  36. Gonzales MF, Davis RL (1988) Neuropathology of acquired immunodeficiency syndrome. Neuropathol Appl Neurobiol 14: 345–363PubMedGoogle Scholar
  37. Gourdou I, Mabrouk K, Harkiss G, Marchot P, Watt N, Hery F, Vigne R (1990) Neurotoxicity in mice due to cysteine-rich parts of visna virus and HIV-1 Tat proteins. C R Acad Sci [III] 311: 149–155Google Scholar
  38. Green JE, Begley CG, Wagner DK, Waldmann TA, Jay G (1989) trans activation of granulocyte-macrophage colony-stimulating factor and the interleukin-2 receptor in transgenic mice carrying the human T-lymphotropic virus type 1 tax gene. Mol Cell Biol 9: 4731–4737PubMedGoogle Scholar
  39. Gunzburg WH, Heinemann F, Wintersperger S, Miethke T, Wagner H, Erfle V, Salmons B (1993) Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat. Nature 364: 154–158PubMedGoogle Scholar
  40. Hahn H, Baunach G, Bräutigam S, Mergia A, Neumann-Haefelin D, Daniel MD, McClure MO, Rethwilm A (1994) Reactivity of primate sera to foamy virus gag and bet proteins. J Gen Virol 75: 2635–2644PubMedGoogle Scholar
  41. He F, Sun JD, Garrett ED, Cullen BR (1993) Functional organization of the Bel-1 trans activator of human foamy virus. J Virol 67: 1896–1904PubMedGoogle Scholar
  42. Herchenröder O, Renne R, Loncar D, Cobb EK, Murthy KK, Schneider J, Mergia A, Luciw PA (1994) Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology 201: 187–199PubMedGoogle Scholar
  43. Hildreth JE, Orentas RJ (1989) Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science 244: 1075–1078PubMedGoogle Scholar
  44. Hinrichs SH, Nerenberg M, Reynolds RK, Khoury G, Jay G (1987) A transgenic mouse model for human neurofibromatosis. Science 237: 1340–1343Google Scholar
  45. Hogan B, Constantini F, Lacy E (1986) Manipulating the mouse embryo. A laboratory manual. Cold Spring Harbor Laboratory, New YorkGoogle Scholar
  46. Hooks JJ, Gibbs CJ Jr (1975) The foamy viruses. Bacteriol Rev 39: 169–185PubMedGoogle Scholar
  47. Hook JJ, Gibbs CJ Jr, Cutchins EC, Rogers NG, Lampert P, Gajdusek DC (1972) Characterization and distribution of two new foamy viruses isolated from chimpanzees. Arch Gesamte Virusforsch 38: 38–55Google Scholar
  48. Hooks JJ, Burns W, Hayashi K, Geis S, Notkins AL (1976) Viral spread in the presence of neutralizing antibody: mechanisms of persistence in foamy virus infection. Infect Immun 14: 1172–1181PubMedGoogle Scholar
  49. Horth M, Lambrecht B, Chuah Lay Khim M, Bex F, Thiriart C, Ruysschaert JM, Burny A, Brasseur R (1991) Theoretical and functional analysis of the SIV fusion peptide. EMBO J 10: 2747–2755PubMedGoogle Scholar
  50. Keller A, Partin KM, Löchelt M, Bannert H, Flügel RM, Cullen BR (1991) Characterization of the transcriptional trans activator of human foamy retrovirus. J Virol 65: 2589–2594PubMedGoogle Scholar
  51. Keller A, Garrett ED, Cullen BR (1992) The Bel-1 protein of human foamy virus activates human immunodeficiency virus type 1 gene expression via a novel DNA target site. J Virol 66: 3946–3949PubMedGoogle Scholar
  52. Kennedy-Stoskopf S, Stoskopf MK, Eckhaus MA, Strandberg JD (1986) Isolation of a retrovirus and a herpesvirus from a captive California sea lion. J Wildl Dis 22: 156–164PubMedGoogle Scholar
  53. Kleihues P, Lang W, Burger PC, Budka H, Vogt M, Maurer R, Lüthy R, Siegenthaler W (1985) Progressive diffuse leukoencephalopathy in patients with acquired immunodeficiency syndrome (AIDS). Acta Neuropathol (Berl) 333: 339Google Scholar
  54. Kupiec JJ, Kay A, Hayat M, Ravier R, Peries J, Galibert F (1991) Sequence analysis of the simian foamy virus type 1 genome. Gene 101: 185–194PubMedGoogle Scholar
  55. Lagaye S, Vexiau P, Morozov V, Guenebaut-Claudet V, Tobaly-Tapiero J, Canivet M, Cathelineau G, Peries J, Emanoil-Ravier R (1992) Human spumaretrovirus-related sequences in the DNA of leukocytes from patients with Graves’ disease. Proc Natl Acad Sci USA 89: 10070–10074PubMedGoogle Scholar
  56. Landau NR, Page KA, Littman DR (1991) Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J Virol 65: 162–169PubMedGoogle Scholar
  57. Le Guern M, Levy JA (1992) Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2 infected cells. Pseudotypes virions produced with expanded cellular host range. Proc Natl Acad USA 89: 363–367Google Scholar
  58. Lee AH, Lee KJ, Kim S, Sung YC (1992) Transactivation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by the human foamy virus bell protein requires a specific DNA sequence. J Virol 66: 3236–3240PubMedGoogle Scholar
  59. Lee CW, Chang J, Lee KJ, Sung YC (1994) The Bell protein of human foamy virus contains one positive and two negative control regions which regulate a distinct activation domain of 30 amino acids. J Virol 68: 2708–2719PubMedGoogle Scholar
  60. Lee KJ, Lee AH, Sung YC (1993) Multiple positive and negative cis-acting elements that mediate transactivation by bell in the long terminal repeat of human foamy virus. J Virol 67: 2317–2326PubMedGoogle Scholar
  61. Leonard JM, Abramczuk JW, Pezen DS, Rutledge R, Belcher JH, Hakim F, Shearer G, Lamperth L, Travis W, Fredrickson T, Notkins AL, Martin MA (1988) Development of disease and virus recovery in transgenic mice containing HIV proviral DNA. Science 242: 1665–1670PubMedGoogle Scholar
  62. Lewis SH, Reynolds-Kohier C, for HE, Nelson JA (1990) HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses. Lancet 335: 565–568PubMedGoogle Scholar
  63. Löchelt M, Zentgraf H, Flügel RM (1991) Construction of an infectious DNA clone of the full length human spumaretrovirus genome and mutagenesis of the bel-1 gene. Virology 184: 34–54Google Scholar
  64. Löchelt M, Aboud M, Flügel RM (1993) Increase in the basal transcriptional activity of the human foamy virus internal promoter by the homologous long terminal repeat promoter in cis. Nucleic Acids Res 21: 4226–4230PubMedGoogle Scholar
  65. Löchelt M, Flügel RM, Aboud M (1994) The human foamy virus internal promoter directs the expression of the functional Bel 1 transactivator and Bet protein early after infection. J Virol 68: 638–645PubMedGoogle Scholar
  66. Loh P (1993) Spumavirinae. In: Levy J (ed) The retroviridae. Plenum, New York, pp 361–397Google Scholar
  67. Loh PC, Achong BG, Epstein MA (1977) Further biological properties of the human syncytial virus. Intervirology 8: 204–217PubMedGoogle Scholar
  68. Loh PC, Matsuura F, Mizumoto C (1980) Seroepidemiology of human syncytial virus: antibody prevalence in the Pacific. Intervirology 13: 87–90PubMedGoogle Scholar
  69. Lusso P, Ensoli B, Markham PD, Ablashi DV, Salahuddin SZ, Tschachler E, Wong-Staal F, Gallo RC (1989) Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature 337: 370–373PubMedGoogle Scholar
  70. Lusso P, De Maria A, Malnati M, Lori F, DeRocco SE, Baseler M, Gallo RC (1991) Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6. Nature 349: 533–535PubMedGoogle Scholar
  71. Mahnke C, Löchelt M, Bannert H, Flügel RM (1990) Specific enzyme-linked immunosorbent assay for the detection of antibodies to the human spumavirus. J Virol Methods 29: 13–22PubMedGoogle Scholar
  72. Mahnké C, Kashaiya P, Rössler J, Bannert H, Levin A, Blattner WA, Dietrich M, Luande J, Löchelt M, Friedman-Kien A, Komaroff AL, Loh PC, Westarp ME, Flügel RM (1992) Human spumavirus antibodies in sera from african patients. Arch Virol 123: 243–253PubMedGoogle Scholar
  73. Maier H, Budka H, Lassmann H, Pohl P (1989) Vacuolar myelopathy with multinucleated giant cells in the acquired immune deficiency syndrome (AIDS). Light and electron microscopic distribution of human immunodeficiency virus (HIV) antigens. Acta Neuropathol (Berl) 78: 497–503Google Scholar
  74. Maurer B, Bannert H, Darai G, Flügel RM (1988) Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. J Virol 62: 1590–1597PubMedGoogle Scholar
  75. McClure MO, Bienasz PD, Schulz TF, Chrystie IL, Simpson G, Aguzzi A, Hoad JG, Cunningham A, Kirkwood J, Weiss RA (1994) Isolation of a new foamy virus from orangutans. J Virol 68: 7124–7130PubMedGoogle Scholar
  76. Mergia A (1994) Simian foamy virus type 1 contains a second promoter located at the 3′ end of the env gene. Virology 199: 219–222PubMedGoogle Scholar
  77. Mergia A, Luciw PA (1991) Replication and regulation of primate foamy viruses. Virology 184: 475–482PubMedGoogle Scholar
  78. Mergia A, Pratt Lowe E, Shaw KE, Renshaw Gegg LW, Luciw PA (1992) cis-acting regulatory regions in the long terminal repeat of simian foamy virus type 1. J Virol 66: 251–257PubMedGoogle Scholar
  79. Mergia A, Renshaw Gegg LW, Stout MW, Renne R, Herchenröder O (1993) Functional domains of the simian foamy virus type 1 transcriptional transactivator (Taf). J Virol 67: 4598–4604PubMedGoogle Scholar
  80. Miller CL, Garner R, Paetkau V (1992) An activation-dependent, T-lymphocyte-specific transcriptional activator in the mouse mammary tumor virus env gene. Mol Cell Biol 12: 3262–3272PubMedGoogle Scholar
  81. Mosca JD, Bednarik DP, Raj NBK, Rosen CA, Sodroski JG, Haseltine WA, Pitha PM (1987) Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus. Nature 325: 67–70PubMedGoogle Scholar
  82. Müller HK, Ball G, Epstein MA, Achong BG, Lenoir G, Levin A (1980) The prevalence of naturally occurring antibodies to human syncytial virus in East African populations. J Gen Virol 47: 399–406PubMedGoogle Scholar
  83. Muranyi W, Flügel RM (1991) Analysis of splicing patterns of human spumaretrovirus by polymerase chain reaction reveals complex RNA structures. J Virol 65: 727–735PubMedGoogle Scholar
  84. Nara PL, Robey WG, Arthur LO, Gonda MA, Asher DM, Yanagihara R, Gibbs CJ Jr, Gajdusek DC, Fischinger PJ (1987) Simultaneous isolation of simian foamy virus and HTLV-III/LAV from chimpanzee lymphocytes following HTLV-III or LAV inoculation. Arch Virol 92: 183–186PubMedGoogle Scholar
  85. Nerenberg ML, Wiley CA (1989) Degeneration of oxidative muscle fibers in HTLV-1 tax transgenic mice. Am J Pathol 135: 1025–1033PubMedGoogle Scholar
  86. Nerenberg M, Hinrichs SH, Reynolds RK, Khoury G, Jay G (1987) The tat gene of human T-lympho-tropic virus type 1 induces mesenchymal tumors in transgenic mice. Science 237: 1324–1329PubMedGoogle Scholar
  87. Netzer KO, Rethwilm A, Maurer B, Ter Meulen V (1990) Identification of the major immunogenic structural proteins of human foamy virus. J Gen Virol 71: 1237–1241PubMedGoogle Scholar
  88. Neumann-Haefelin D, Rethwilm A, Bauer G, Gudat F, Zur Hausen H (1983) Characterization of a foamy virus isolated from Cercopithecus aethiops lymphoblastoid cells. Med Microbiol Immunol (Berl) 172: 75–86Google Scholar
  89. Neumann-Haefelin D, Fleps U, Renne R, Schweizer M (1993) Foamy viruses. Intervirology 35: 196–207PubMedGoogle Scholar
  90. Nosaka T, Ariumi Y, Sakurai M, Takeuchi R, Hatanaka M (1993) Novel internal promoter/enhancer of HTLV-I for Tax expression. Nucleic Acids Res 21: 5124–5129PubMedGoogle Scholar
  91. Pantaleo G, Poli G, Butini L, Fox C, Dayton Al, Fauci AS (1991) Dissociation between syncytia formation and HIV spreading. Suppression of syncytia formation does not necessarily reflect inhibition of HIV infection. Eur J Immunol 21: 1771–1774PubMedGoogle Scholar
  92. Petito CK (1988) Review of central nervous system pathology in human immunodeficiency virus infection. Ann Neurol 23 Suppl: S54–S57PubMedGoogle Scholar
  93. Petito CK, Navia BA, Cho ES, Jordan BD, George DC, Price RW (1985) Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med 312: 874–879PubMedGoogle Scholar
  94. Renne R, Friedl E, Schweizer M, Fleps U, Turek R, Neumann-Haefelin D (1992) Genomic organization and expression of simian foamy virus type 3 (SFV-3). Virology 186: 597–608PubMedGoogle Scholar
  95. Renshaw RW, Casey JW (1994) Analysis of the 5’ long terminal repeat of bovine syncytial virus. Gene 141: 221–224PubMedGoogle Scholar
  96. Rethwilm A (1995) Regulation of foamy virus gene expression. Curr Top Microbiol Immunol 193 (in press)Google Scholar
  97. Rethwilm A, Baunach G, Netzer KO, Maurer B, Borisch B, Ter Meulen V (1990) Infectious DNA of the human spumaretrovirus. Nucleic Acids Res 18: 733–738PubMedGoogle Scholar
  98. Rethwilm A, Erlwein O, Baunach G, Maurer B, Ter Meulen V (1991) The transcriptional transactivator of human foamy virus maps to the bel 1 genomic region. Proc Natl Acad Sci USA 88: 941–945PubMedGoogle Scholar
  99. Rosen CA (1991) Regulation of HIV gene expression by RNA-protein interactions. Trends Genet 7: 9–14PubMedGoogle Scholar
  100. Saib A, Peries J, de The H (1993) A defective human foamy provirus generated by pregenome splicing. EM BO J 12: 4439–4444Google Scholar
  101. Santillana Hayat M, Rozain F, Bittoun P, Chopin Robert C, Lasneret J, Peries J, Canivet M (1993) Transient immunosuppressive effect induced in rabbits and mice by the human spumaretrovirus prototype HFV (human foamy virus). Res Virol 144: 389–396Google Scholar
  102. Schliephake A, Rethwilm A (1994) Nuclear localization of foamy virus gag precursor protein. J Virol 68: 4946–4954PubMedGoogle Scholar
  103. Schnitzer TJ (1982) Simian foamy virus pseudotypes of vesicular stomatitis virus: production and use in sero-epidemiological investigations. J Gen Virol 59: 203–206PubMedGoogle Scholar
  104. Schweizer M, Renne R, Neumann-Haefelin D (1989) Structural analysis of proviral DNA in simian foamy virus (LK-3)-infected cells. Arch Virol 109: 103–104PubMedGoogle Scholar
  105. Schweizer M, Turek R, Hahn H, Schliephake A, Netzer KO, Eder G, Reinhardt M, Rethwilm A, Neumann-Haefelin D (1994a) Markers of foamy virus (FV) infection in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected FV prevalence in man. AIDS Res Hum Retrovir uses (in press)Google Scholar
  106. Schweizer M, Turek R, Reinhardt M, Neumann-Haefelin D (1994b) Absence of foamy virus DNA in Graves’ disease. AIDS Res Hum Retroviruses 10: 601–605PubMedGoogle Scholar
  107. Sharpe AH, Hunter JJ, Chassler P, Jänisch R (1990) Role of abortive retroviral infection of neurons in spongiform CNS degeneration. Nature 346: 181–183PubMedGoogle Scholar
  108. Siekevitz M, Joseph SF, Dukovich M, Peffer N, Wong-Staal F, Greene WC (1987) Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. Science 238: 1575–1578PubMedGoogle Scholar
  109. Stancek D, Stancekova-Gressnerova M, Janotka M, Hnilica P, Oravec D (1975) Isolation and some serological and epidemiological data on the viruses recovered from patients with subacute thyroiditis de Quervain. Med Microbiol Immunol (Berl) 161: 133–144Google Scholar
  110. Teich N (1984) Taxonomy of retroviruses. In: Weiss RA, Teich N, Varmus HE, Coffin J (eds) RNA tumor viruses. Cold Spring Harbor Laboratory, New York, pp 25–208Google Scholar
  111. Truneh A, Buck D, Cassatt DR, Juszczak R, Kassis S, Ryu SE, Healey D, Sweet R, Sattentau Q (1991) A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion. J Biol Chem 266: 5942–5948PubMedGoogle Scholar
  112. Venkatesh LK, Chinnadurai G (1993) The carboxy-terminal transcription enhancement region of the human spumaretrovirus transactivator contains discrete determinants of the activator function. J Virol 67: 3868–3876PubMedGoogle Scholar
  113. Venkatesh LK, Theodorakis PA, Chinnadurai G (1991) Distinct cis-acting regions in U3 regulate trans-activation of the human spumaretrovirus long terminal repeat by the viral bell gene product. Nucleic Acids Res 19: 3661–3666PubMedGoogle Scholar
  114. Vogel J, Hinrichs SH, Reynolds RK, Luciw PA, Jay G (1988) The HIV tat gene induces dermal lesions resembling Kaposi’s sarcoma in transgenic mice. Nature 335: 606–611PubMedGoogle Scholar
  115. Watanabe T, Seiki M, Tsujimoto H, Miyoshi I, Hayami M, Yoshida M (1985) Sequence homology of the simian retrovirus genome with human T-cell leukemia virus type I. Virology 144: 59–65PubMedGoogle Scholar
  116. Watanabe T, Seiki M, Hirayama Y, Yoshida M (1986) Human T-cell leukemia virus type I is a member of the African subtype of simian viruses (STLV). Virology 148: 385–388PubMedGoogle Scholar
  117. Weissenberger J, Flügel R (1994) Identification and characterization of the bel-3 protein of human foamy virus. AIDS Res Hum Retroviruses 10: 595–600PubMedGoogle Scholar
  118. Werner J, Gelderblom HR (1979) Isolation of foamy virus from patients with de Quervain thyroiditis. Lancet 2: 258–259PubMedGoogle Scholar
  119. Westarp ME, Kornhuber HH, Rössler J, Flügel RM (1992) Human spuma virus antibodies in armyo-trophic lateral sclerosis. Neurol Psychiatry Brain Res 1: 1–4Google Scholar
  120. Young D, Samuels J, Clarke JK (1973) A foamy virus of possible human origin isolated in BHK-21 cells. Arch Gesamte Virusforsch 42: 228–234PubMedGoogle Scholar
  121. Yu SF, Linial ML (1993) Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay. J Virol 67: 6618–6624PubMedGoogle Scholar
  122. Zider A, Mashhour B, Fergelot P, Grimber G, Vernet M, Hazan U, Couton D, Briand P, Cavard C (1993) Dispensable role of the NF-kappa B sites in the UV-induction of the HIV-1 LTR in transgenic mice. Nucleic Acids Res 21: 79–86PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • A. Aguzzi
    • 1
  • S. Marino
    • 1
  • R. Tschopp
    • 1
  • A. Rethwilm
    • 2
  1. 1.Institute of Neuropathology, Department of PathologyUniversity of ZürichZürichSwitzerland
  2. 2.Institute of VirologyUniversity of WürzburgWürzburgGermany

Personalised recommendations